Evidence map›Paper›PMID 33335556›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Luteolin Protects Pheochromocytoma (PC-12) Cells against A

Han-Rui Wang, Si-Ying Pei, Dong-Xu Fan, Yan-Hui Liu, Xiao-Feng Pan, Fan-Xu Song, Shu-Hua Deng, Hong-Bin Qiu, Ning Zhang

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Therapeutic Expedition of Luteolin against Brain-related Disorders: An Updated Review.Combinatorial chemistry & high throughput screening · 2025
    Review
  3. Review
  4. Article
  5. Luteolin for neurodegenerative diseases: a review.Pharmacological reports : PR · 2024
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Han-Rui WangCollege of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.ORCID https://orcid.org/0000-0003-4045-4966
Si-Ying PeiCollege of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.ORCID https://orcid.org/0000-0003-2890-2367
Dong-Xu FanDepartment of Vascular Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang, China.ORCID https://orcid.org/0000-0003-0390-231X
Yan-Hui LiuDepartment of Vascular Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang, China.
Xiao-Feng PanDepartment of Nursing, Jiamusi Central Hospital of Heilongjiang Province, Jiamusi, Heilongjiang, China.ORCID https://orcid.org/0000-0002-2767-1096
Fan-Xu SongDepartment of Pediatric Neurology, The Third Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang, China.ORCID https://orcid.org/0000-0003-4240-1040
Shu-Hua DengDepartment of Nursing, Jiamusi Central Hospital of Heilongjiang Province, Jiamusi, Heilongjiang, China.ORCID https://orcid.org/0000-0002-2679-2742
Hong-Bin QiuCollege of Public Health, Jiamusi University, Jiamusi, Heilongjiang, China.ORCID https://orcid.org/0000-0002-0307-9995
Ning ZhangCollege of Pharmacy, Jiamusi College, Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.ORCID https://orcid.org/0000-0002-4302-0963

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regulatory effect of luteolin on the progression of Alzheimer's disease (AD) remains unclear from the perspective of apoptosis. The present study aimed to investigate the protective effects of luteolin against A

Identifiers

PMID33335556
PMCPMC7723489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.